Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice.
about
Current and emerging treatment strategies for Duchenne muscular dystrophyEnhanced Ca2+ transport and muscle relaxation in skeletal muscle from sarcolipin-null miceG-CSF does not influence C2C12 myogenesis despite receptor expression in healthy and dystrophic skeletal muscle.Sarcopenia: etiology, clinical consequences, intervention, and assessment.Insulin-like growth factor 1 physiology: lessons from mouse models.Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy.The role of proteases in excitation-contraction coupling failure in muscular dystrophy.Interaction between bone and muscle in older persons with mobility limitationsStructural and functional evaluation of branched myofibers lacking intermediate filamentsE-peptides control bioavailability of IGF-1.Recent advances in genetic predisposition to clinical acute lung injury.αCAR IGF-1 vector targeting of motor neurons ameliorates disease progression in ALS mice.Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling.Recent Insights into Insulin-Like Growth Factor Binding Protein 2 Transcriptional Regulation.Emerging drugs for treating skeletal muscle injury and promoting muscle repair.Prospect for pharmacological therapies to treat skeletal muscle dysfunction.The effect of taurine and β-alanine supplementation on taurine transporter protein and fatigue resistance in skeletal muscle from mdx mice.Optical prediction of single muscle fiber force production using a combined biomechatronics and second harmonic generation imaging approach
P2860
Q26741535-09637136-DCCD-473D-B17D-173CA7FFA7DEQ28509941-DEF4F672-5AF1-463A-A131-0C915A4B7699Q33579922-4DCB2158-83D8-45F3-B8DF-3B16AFC91D00Q33706637-C637348C-3F33-4D3A-8E4C-B9B97035AF03Q33846069-06FBFBE5-87DC-4361-B685-38404B88453BQ34756106-F2B0AD77-3F14-4A12-BD59-9DBDFCFDCCD5Q34800803-C6DFC005-26F3-487B-A1C5-3B656763E24BQ36100758-F11AF58B-4536-4681-9FBB-E0AA14E49F5BQ36114637-3803E996-960E-47EC-BBF4-0C4479D52431Q36459287-1E69C49B-1262-4426-A36F-7E0AA1FEFFF2Q37190198-79CD27E9-0FBC-4CBF-928E-86549BEDA39BQ37307491-50242295-625D-4700-8B41-9C794CD01BB0Q37338902-7BC4B711-6951-42E3-A0F7-0AE33BECF61EQ37723228-0176C694-36C5-48E9-A2EE-761920F6076DQ37842502-222D0956-1155-4B74-B0C9-D457D233CB05Q38264369-B381003C-D46D-4F0E-A9EC-97EEF3131D85Q51625827-D5A779D0-0130-4FAE-B7F4-2BAA0B8850EFQ58118806-01D9B2F6-2758-4CFE-99D3-F27DECA2FEEA
P2860
Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Muscle-specific overexpression ...... bers from dystrophic mdx mice.
@en
Muscle-specific overexpression ...... bers from dystrophic mdx mice.
@nl
type
label
Muscle-specific overexpression ...... bers from dystrophic mdx mice.
@en
Muscle-specific overexpression ...... bers from dystrophic mdx mice.
@nl
prefLabel
Muscle-specific overexpression ...... bers from dystrophic mdx mice.
@en
Muscle-specific overexpression ...... bers from dystrophic mdx mice.
@nl
P2093
P2860
P1476
Muscle-specific overexpression ...... bers from dystrophic mdx mice.
@en
P2093
Chris van der Poel
Jonathan D Schertzer
Thea Shavlakadze
P2860
P304
P356
10.1152/AJPCELL.00399.2007
P577
2007-11-07T00:00:00Z